Document 0660
 DOCN  M95A0660
 TI    Prevention and treatment studies for CMV open. 
 DT    9510
 SO    Treat Rev. 1995 Mar/Apr;(no 17):5. Unique Identifier : AIDSLINE
       AIDS/95700323
 AB    A herpesvirus called cytomegalovirus (CMV) is treatable with either
       ganciclovir or foscarnet. Both have previously been delivered
       intravenously, however, an oral form of ganciclovir has been produced
       for use in the maintenance stage. Studies show the intravenous delivery
       to be a little better than the oral form. Oral ganciclovir for
       prevention is now available through an expanded access program. The
       manufacturer will need to be contacted to register. Another study
       comparing different treatments (IV ganciclovir, an eye implant with oral
       ganciclovir, and an eye implant alone) is also seeking participants, as
       is a study using foscarnet for the treatment of CMV colitis.
 DE    Administration, Oral  Anemia/CHEMICALLY INDUCED/THERAPY  Colitis/DRUG
       THERAPY/VIROLOGY  Cytomegalovirus Infections/DRUG THERAPY/*PREVENTION &
       CONTROL  Erythropoietin/THERAPEUTIC USE  Foscarnet/*THERAPEUTIC USE
       Ganciclovir/ADMINISTRATION & DOSAGE/ADVERSE EFFECTS/THERAPEUTIC  USE
       Granulocyte Colony-Stimulating Factor/THERAPEUTIC USE  Human  Infusions,
       Intravenous  Neutropenia/CHEMICALLY INDUCED/THERAPY  NEWSLETTER ARTICLE
       RANDOMIZED CONTROLLED TRIAL  CLINICAL TRIAL

       SOURCE: National Library of Medicine.  NOTICE: This material may be
       protected by Copyright Law (Title 17, U.S.Code).